VENTUS Trademark

Trademark Overview


On Tuesday, March 16, 2021, a trademark application was filed for VENTUS with the United States Patent and Trademark Office. The USPTO has given the VENTUS trademark a serial number of 90581391. The federal status of this trademark filing is SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Wednesday, October 16, 2024. This trademark is owned by VENTUS MEDICAL LIMITED. The VENTUS trademark is filed in the Smoker's Products, Pharmaceutical Products, and Medical Instrument Products categories with the following description:

Prescription and non-prescription medicines, namely, medicines intended as a medical aid to smoking cessation in the nature of smoking cessation preparations; Nicotine replacement therapeutic medicines for smoking cessation, namely, substances containing nicotine and nicotine-based derivative compositions in the nature of smoking cessation preparations; Medicaments and medicated solutions being smoking cessation preparations for electric and electronic smoking devices for medical use, in particular for use as nicotine replacement and withdrawal therapies and as medical smoking cessation aids

Electric and electronic smoking devices, in particular personal oral vaporizers for smoking purposes and electric and electronic cigarettes, and flavorings, other than essential oils, and liquid nicotine solutions therefor; Tobacco substitute compositions for non-medical use; Liquid solutions containing nicotine and nicotine-based derivative compositions for electric and electronic cigarettes; Electronic devices for the creation of and subsequent inhalation of an aerosol containing nicotine and nicotine-based derivative compositions, namely, oral vaporizers and electric and electronic cigarettes

Medical devices, in particular medical devices for the delivery of nicotine and nicotine-based derivative compositions to humans in the nature of inhalers for medical use; inhalators, aerosol creating and dispensing devices in the nature of aerosol dispensers, nebulizers, vaporizers, all for medical use, and particularly for delivering to a human, by means of inhalation, a medicinally or therapeutically effective amount of nicotine and nicotine-based derivative composition
ventus

General Information


Serial Number90581391
Word MarkVENTUS
Filing DateTuesday, March 16, 2021
Status814 - SU - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateWednesday, October 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements


Goods and ServicesPrescription and non-prescription medicines, namely, medicines intended as a medical aid to smoking cessation in the nature of smoking cessation preparations; Nicotine replacement therapeutic medicines for smoking cessation, namely, substances containing nicotine and nicotine-based derivative compositions in the nature of smoking cessation preparations; Medicaments and medicated solutions being smoking cessation preparations for electric and electronic smoking devices for medical use, in particular for use as nicotine replacement and withdrawal therapies and as medical smoking cessation aids
Pseudo MarkVENT US
Goods and ServicesElectric and electronic smoking devices, in particular personal oral vaporizers for smoking purposes and electric and electronic cigarettes, and flavorings, other than essential oils, and liquid nicotine solutions therefor; Tobacco substitute compositions for non-medical use; Liquid solutions containing nicotine and nicotine-based derivative compositions for electric and electronic cigarettes; Electronic devices for the creation of and subsequent inhalation of an aerosol containing nicotine and nicotine-based derivative compositions, namely, oral vaporizers and electric and electronic cigarettes
Goods and ServicesMedical devices, in particular medical devices for the delivery of nicotine and nicotine-based derivative compositions to humans in the nature of inhalers for medical use; inhalators, aerosol creating and dispensing devices in the nature of aerosol dispensers, nebulizers, vaporizers, all for medical use, and particularly for delivering to a human, by means of inhalation, a medicinally or therapeutically effective amount of nicotine and nicotine-based derivative composition

Classification Information


International Class034 - Tobacco; smokers' articles; matches.
US Class Codes002, 008, 009, 017
Class Status Code6 - Active
Class Status DateWednesday, June 16, 2021
Primary Code034
First Use Anywhere DateThursday, February 15, 2024
First Use In Commerce DateThursday, February 15, 2024

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 16, 2021
Primary Code005
First Use Anywhere DateThursday, February 15, 2024
First Use In Commerce DateThursday, February 15, 2024

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, June 16, 2021
Primary Code010
First Use Anywhere DateThursday, February 15, 2024
First Use In Commerce DateThursday, February 15, 2024

Trademark Owner History


Party NameVENTUS MEDICAL LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLiverpool L192RF
GB

Party NameVENTUS MEDICAL LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLiverpool L192RF
GB

Trademark Events


Event DateEvent Description
Monday, October 18, 2021ASSIGNED TO EXAMINER
Friday, March 19, 2021NEW APPLICATION ENTERED
Wednesday, June 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, October 21, 2021NON-FINAL ACTION E-MAILED
Thursday, October 21, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 21, 2021NON-FINAL ACTION WRITTEN
Tuesday, November 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, July 11, 2022OPPOSITION INSTITUTED NO. 999999
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, January 24, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, January 4, 2023OPPOSITION TERMINATED NO. 999999
Wednesday, January 4, 2023TTAB RELEASE CASE TO TRADEMARKS
Wednesday, January 4, 2023OPPOSITION DISMISSED NO. 999999
Tuesday, February 14, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 1, 2023ASSIGNED TO EXAMINER
Tuesday, July 11, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, July 11, 2023SOU EXTENSION 1 FILED
Tuesday, July 11, 2023SOU EXTENSION 1 GRANTED
Thursday, July 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2024SOU EXTENSION 2 GRANTED
Wednesday, February 14, 2024SOU EXTENSION 2 FILED
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 5, 2024USE AMENDMENT FILED
Monday, March 25, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 8, 2024NON-FINAL ACTION E-MAILED
Tuesday, March 5, 2024TEAS STATEMENT OF USE RECEIVED
Wednesday, March 27, 2024STATEMENT OF USE PROCESSING COMPLETE
Monday, April 8, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, April 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 16, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 16, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 16, 2024ASSIGNED TO LIE
Monday, July 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED